Title: Mark Fredrick Mccarty: Innovator in Medical Composition
Introduction
Mark Fredrick Mccarty is an inventor based in San Diego, CA. He has made significant contributions to the field of medical compositions, particularly in the area of inhibiting NADPH oxidase activity. His innovative work focuses on the use of phycobilins as prodrugs for treating medical conditions associated with NADPH oxidase activity.
Latest Patents
Mark Fredrick Mccarty holds a patent titled "Composition For Inhibiting Nadph Oxidase Activity." This patent discloses the prodrug activity of phycobilins as inhibitors of NADPH oxidase activity. The compositions described facilitate the administration of phycobilins, which are useful in the prophylaxis and treatment of related medical conditions. Notably, he has 0 patents registered under his name.
Career Highlights
Throughout his career, Mccarty has worked with various companies, including PCB Associates, Inc. and his own venture, Mccarty, Mark Fredrick. His work has been instrumental in advancing the understanding of NADPH oxidase activity and its implications in medical treatments.
Collaborations
Mark has collaborated with notable individuals in his field, including Sheldon Saul Hendler and David Michael Rorvik. These collaborations have contributed to the development of his innovative ideas and research.
Conclusion
Mark Fredrick Mccarty is a dedicated inventor whose work in medical compositions has the potential to impact the treatment of various medical conditions. His focus on phycobilins and their application in inhibiting NADPH oxidase activity showcases his commitment to advancing medical science.